TREATMENT AND OUTCOMES OF TYPE 2 MYOCARDIAL INFARCTION COMPARED WITH TYPE 1 MYOCARDIAL INFARCTION
Sign Up to like & getrecommendations! Published in 2019 at "Journal of the American College of Cardiology"
DOI: 10.1016/s0735-1097(19)30769-7
Abstract: Type 2 myocardial infarction (MI) is defined by elevated cardiac biomarkers and evidence of ischemia due to a mismatch in myocardial oxygen supply and demand. Type 2 MI patients are usually misclassified under the diagnosis… read more here.
Keywords: treatment outcomes; outcomes type; infarction compared; infarction ... See more keywords
Comparison of outcomes between type 2 diabetic and non-diabetic incident hemodialysis patients with functioning arteriovenous fistulas
Sign Up to like & getrecommendations! Published in 2019 at "Medicine"
DOI: 10.1097/md.0000000000018216
Abstract: Supplemental Digital Content is available in the text read more here.
Keywords: outcomes type; diabetic incident; non diabetic; type diabetic ... See more keywords
Sodium intake, circulating microvesicles and cardiovascular outcomes in type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2019 at "Current diabetes reviews"
DOI: 10.2174/1573399815666190212120822
Abstract: There is ongoing debate surrounding the complex relationship between dietary sodium intake and cardiovascular morbidity and mortality. The existing literature consists largely of observational studies that have demonstrated positive, negative, U-/J-shaped or unclear associations between… read more here.
Keywords: sodium intake; type diabetes; cardiovascular outcomes; outcomes type ... See more keywords
Canagliflozin and cardiovascular outcomes in Type 2 diabetes.
Sign Up to like & getrecommendations! Published in 2020 at "Future cardiology"
DOI: 10.2217/fca-2020-0029
Abstract: SGLT2 inhibitors have risen to prominence in recent years as Type 2 diabetes mellitus medications with favorable effects on cardiovascular (CV) and renal outcomes. Canagliflozin is a US FDA-approved SGLT2 inhibitor that has demonstrated CV and renal… read more here.
Keywords: canagliflozin cardiovascular; cardiology; cardiovascular outcomes; outcomes type ... See more keywords